Valuation: HANDOK Inc.

Market Cap 109B 81.56M 72.5M 67.19M 61.14M 115M 7.74B 117M 808M 317M 4.04B 306M 300M 12.88B P/E 2024
-3.16x
P/E 2025 -69x
Enterprise Value 459B 344M 306M 284M 258M 487M 32.69B 495M 3.41B 1.34B 17.06B 1.29B 1.27B 54.38B EV / Sales 2024
0.95x
EV / Sales 2025 0.93x
Free-Float
52.22%
Yield 2024
1.66%
Yield 2025 -
1 day+2.57%
1 week-2.67%
Current month-0.71%
1 month-0.95%
3 months-0.36%
6 months-21.85%
Current year-25.27%
1 week 7,970
Extreme 7970
8,600
1 month 7,970
Extreme 7970
9,360
Current year 6,460
Extreme 6460
11,820
1 year 6,460
Extreme 6460
12,150
3 years 6,460
Extreme 6460
20,300
5 years 6,460
Extreme 6460
24,800
10 years 6,460
Extreme 6460
44,750
Manager TitleAgeSince
Chief Executive Officer 69 -
Chief Executive Officer 68 31/12/1995
Director of Finance/CFO 58 -
Director TitleAgeSince
Chairman 68 31/12/1995
Director/Board Member 69 -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
+2.57%-2.67%-27.97%-32.50% 81.56M
+0.43%+6.59%+56.57%+106.64% 1,120B
+0.90%-2.25%+32.26%+63.73% 616B
+0.71%+3.24%+24.33%+91.33% 504B
-0.13%+5.98%+33.66%+50.18% 367B
+0.52%+0.24%+72.13%+40.11% 360B
-0.95%+4.70%+19.65%+42.71% 288B
-1.98%+3.73%-0.89%+10.43% 258B
-0.35%+4.25%+44.74%+52.06% 234B
-0.75%+3.32%+27.18%+94.07% 194B
Average +0.10%+3.35%+28.17%+51.88% 394.1B
Weighted average by Cap. +0.13%+3.83%+39.33%+71.82%

Financials

2024 2025
Net sales 507B 381M 338M 314M 285M 538M 36.12B 547M 3.77B 1.48B 18.85B 1.43B 1.4B 60.08B 535B 401M 357M 331M 301M 568M 38.09B 577M 3.98B 1.56B 19.88B 1.51B 1.47B 63.37B
Net income -52.56B -39.43M -35.05M -32.48M -29.55M -55.77M -3.74B -56.66M -390M -153M -1.95B -148M -145M -6.22B -2.15B -1.61M -1.44M -1.33M -1.21M -2.28M -153M -2.32M -15.99M -6.27M -79.98M -6.06M -5.93M -255M
Net Debt 317B 238M 212M 196M 178M 337M 22.59B 342M 2.36B 924M 11.79B 893M 874M 37.58B 351B 263M 234M 217M 197M 372M 24.95B 378M 2.6B 1.02B 13.02B 987M 966M 41.51B
Projected Income Statement - Annual - HANDOK Inc.
Logo HANDOK Inc.
Handok Inc is a Korea-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates its business through four segments. The Pharmaceutical segment mainly manufactures and sells prescription and over-the-counter drugs, including treatments for diabetes, hypertension, kidney diseases, respiratory diseases, central nervous system disorders, rare diseases, as well as anticancer drugs. The Medical Device segment mainly sells medical devices and diagnostic reagents. The Contract Manufacturing segment mainly provides contract manufacturing and quality control services for pharmaceuticals. The Real Estate Leasing segment mainly engages in the real estate leasing business.
Employees
910
Date Price Change Volume
16/10/26 ₩8,370.00 +2.57% 1,751
15/10/26 ₩8,160.00 -1.81% 7,076
14/10/26 ₩8,310.00 +1.84% 4,885
13/10/26 ₩8,160.00 -1.57% 3,503
12/10/26 ₩8,290.00 -3.60% 2,311
  1. Stock Market
  2. Stocks
  3. A002390 Stock